Condition
Cention-N
Total Trials
1
Recruiting
1
Active
1
Completed
0
Key Insights
Highlights
Treatment Research
3 treatments under study, led by Centionn
Related Conditions
Often studied with 6 related conditions
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 1 trials
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
1Total
Not Applicable (1)
Trial Status
Recruiting1
Clinical Trials (1)
Research Network
Common Treatments
- Centionn1
- Resinmodified Glass Ionomer1
- Zirconomer1
Active Sponsors
- Galal Ali Mohamed Ebaid1
Related Conditions
- Class I Restoration1
- Salivary Ph1
- Primary Molars1
- Zirconomer1
- Streptococcus Mutans Count1